Group 1 - West Pharmaceutical Services, Inc. declared a quarterly dividend of $0.22 per share on its common stock, payable on February 4, 2026, to shareholders of record on January 28, 2026 [1] - The company is a global leader in innovative solutions for injectable drug administration, providing high-quality injectable solutions and services [2] - In fiscal year 2024, West generated $2.89 billion in net sales and is included in the Standard & Poor's 500 index [3] Group 2 - West has over 10,000 team members across 50 sites, including 25 manufacturing facilities worldwide, delivering over 41 billion components and devices each year [2] - The company is headquartered in Exton, Pennsylvania, and is traded on the New York Stock Exchange under the ticker symbol WST [3]
West Declares Quarterly Dividend